Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 250

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 250
---
 respect to us and shares of our Class A Common Stock, we refer you to the registration statement and its
exhibits. Statements contained in this prospectus concerning the contents of any contract or any other document are not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement, please see the copy
of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit. The exhibits to the registration statement should be
reviewed for the complete contents of these contracts and documents. A copy of the registration statement and its exhibits may be obtained from the SEC upon the payment of fees prescribed by it. The SEC maintains a website at http://www.sec.gov that
contains reports, proxy and information statements and other information regarding companies that file electronically with it.

Upon
completion of this offering, we will become subject to the information and periodic and current reporting requirements of the Exchange Act, and in accordance therewith, will file periodic and current reports, proxy statements and other information
with the SEC. The registration statement, such periodic and current reports and other information can be obtained electronically by means of the SEC’s website at http://www.sec.gov.

168

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 INDEX TO FINANCIAL STATEMENTS Table of Contents

| Legence Holdings LLC (Predecessor)                                             |     |      |
| Audited Consolidated Financial Statements                                      |     |      |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34)      |     | F-2  |
| Consolidated Balance Sheets as of December                                     
 31, 2024 and December 31, 2023                                                 |     | F-5  |
| Consolidated Statements of Operations for the Years Ended December             
 31, 2024, 2023 and 2022                                                        |     | F-6  |
| Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 
 2024, 2023 and 2022                                                            |     | F-7  |
| Consolidated Statements of Changes in Equity for the Years Ended December 31,  
 2024, 2023 and 2022                                                            |     | F-8  |
| Consolidated Statements of Cash Flows for the Years Ended December             
 31, 2024